Sophia V.
Six years of dieting, $600 on Noom, two Whole30s, and nine months of CrossFit — she got stronger and gained weight. The problem was never discipline.
42 lbs lost in 7 months. HOMA-IR from 4.9 to 1.9. Cycles regular for the first time in years. And a clear taper plan off the medication by month 18 — because staying on it forever was never the goal.
The Bigger Friend Who Did Everything Right and Got Nowhere
Sophia is a 28-year-old marketing coordinator at a mid-sized e-commerce brand — fully remote, nine-hour screen days, living alone in a one-bedroom apartment. She has been "the bigger friend" since middle school. She gained 30 lbs during the pandemic and never lost it. She spent 14 months and over $600 on Noom. She did Whole30 twice — succeeded both rounds, regained both times. She did CrossFit for nine months, got meaningfully stronger, and gained 8 lbs. She tracked calories in MyFitnessPal off and on for six years. She did a round of weekly therapy for emotional eating. Nothing produced lasting change.
Her mother was diagnosed with Type 2 diabetes at 38 and is now on insulin. That timeline is Sophia's greatest fear. She knows her own fasting glucose is 104. She knows her A1c is at the prediabetic threshold. She is 28, watching a 10-year clock tick, and has been told by every provider that she just needs to "eat less and move more" — advice that has produced zero sustainable outcome across six years of genuinely trying.
She came to FLOA terrified of two things in equal measure: becoming her mother's metabolic story, and being on medication "for life" at 28. She wanted a protocol with a built-in exit. She wanted someone to actually look at why none of it had worked. And she wanted to stop doom-scrolling weight loss content at 11pm and feeling worse about herself every morning.
What Six Years of Failed Attempts Masked
- HOMA-IR 4.9 — well above the metabolic syndrome threshold at 28; established insulin resistance
- HbA1c 5.7% and fasting glucose 104 — meets ADA prediabetes criteria; mother's trajectory in plain sight
- Fasting insulin 19 mIU/L — early insulin resistance driving the regain pattern that had defeated every prior diet
- hs-CRP 4.1 mg/L — significantly elevated systemic inflammation for a 28-year-old
- Ferritin 142 — elevated for a young menstruating woman, indicating meaningful inflammatory load
- Gray-zone PCOS labs: LH:FSH ratio 1.8:1, SHBG 28 (suppressed), irregular cycles every 35–45 days — not diagnostic, but mechanistically significant
- Chronic undereating during the day followed by evening overconsumption — a cortisol-driven pattern crashing her metabolism that no prior program had identified
- Sleep latency 45+ minutes; average 6.2 hours; high evening cortisol — the overnight environment working against fat loss
- CrossFit had elevated cortisol further — high-intensity work in an already stressed metabolic environment drove weight gain, not loss
- Deep fear of GLP-1 dependency — "Ozempic face" jokes from her social circle; shame about needing medication at 28
- Six years of failed self-directed attempts producing a learned helplessness pattern and erosion of trust in any new approach
Simple, Conservative, and Built to End
Fasting insulin, HOMA-IR, HbA1c, full thyroid, hs-CRP, sex hormone panel (testosterone, SHBG, LH, FSH), full lipid subfractions, ferritin, vitamin D, B12. Sophia's CGM data and 6-year dieting history reviewed. PCOS-adjacent labs assessed — not diagnostic, but mechanistically relevant to the insulin resistance pattern. Sertraline compatibility with GLP-1 confirmed. DEXA at baseline to establish lean mass protection benchmark from day one.
Semaglutide chosen over tirzepatide — a deliberate decision for a younger, lower-BMI patient with strong fear of dependency. Lower potency, cleaner taper pathway, less risk of overshooting for a patient whose primary goal was to eventually come off entirely. Started at 0.25mg weekly and held at 0.5mg for the entire 7-month program — the dose was never escalated because it didn't need to be. Taper plan built into the protocol from day one: 0.25mg every other week starting at month 7, full discontinuation target at month 18.
The coaching team identified the core pattern: chronic undereating during the workday followed by a high-calorie binge window in the first hour after work — driven by cortisol and depletion, not hunger. The fix was not calorie restriction; it was restructuring when she ate. Substantial breakfast and lunch, moderate dinner. Protein First targeting 100–120g/day. Artificial sweetener load eliminated — it was driving the evening cravings she attributed to willpower failure. The GLP-1 extended her Window of Opportunity to install actual hunger and fullness awareness she had spent 6 years overriding.
Three full-body resistance training sessions weekly with progressive overload, plus two Zone 2 cardio sessions. Explicitly not CrossFit-style high-intensity work — which had elevated her cortisol, driven inflammatory load, and produced 8 lbs of weight gain during her prior 9-month attempt. Lower cortisol, progressive strength stimulus, and Zone 2 for metabolic efficiency. DEXA at month 3 confirmed the approach was working: 1.4 lbs lean muscle gained while 23 lbs of fat mass dropped.
Phone removed from bedroom. Magnesium glycinate added. Consistent sleep window established. Evening cortisol pattern — driven by doom-scrolling weight loss content that was spiking anxiety — addressed directly by restructuring the post-work evening. Sleep latency improved from 45+ minutes to under 20 minutes by month 2. Cortisol pattern normalized within 6 weeks. No peptide optimization added in Phase 1 — the coaching team's deliberate call to keep the protocol simple given her anxiety around medication.
Rather than blanket carb restriction — which had defined both Whole30 attempts and produced the rebound pattern — the coaching team targeted PCOS-adjacent insulin resistance with strategic carb timing around resistance training sessions. Carbs when her insulin sensitivity was highest, not eliminated entirely. Cycles tracked as the insulin sensitivity work progressed — no exogenous hormones prescribed; labs monitored for natural response to metabolic improvement.
Phase by Phase
Food Noise Quieted — Cycle Comes at Day 31
Down 9 lbs. Food noise quieted within week 2 — the constant background preoccupation with eating that had defined her evenings simply receded. Resistance training started with a coach. Her menstrual cycle arrived at day 31 — the most regular cycle she'd had in two years. The insulin sensitivity work was already reaching her hormonal axis within the first month.
→ Down 9 lbs; food noise gone week 2; cycle day 31 — most regular in 2 years
Evening Binge Window Dissolving — Sleep Latency Halved
Down 17 lbs. Energy stabilized throughout the workday. The post-work binge window — the first hour after logging off, when she would eat through whatever was in her kitchen — reduced by half. Sleep latency dropped from 45 minutes to under 20. She was falling asleep in under 20 minutes for the first time she could remember. The doom-scroll evenings were being replaced by meal prep and early sleep.
→ Down 17 lbs; binge window halved; sleep latency under 20 min
Labs Confirm What the Scale Shows — DEXA Shows Muscle Gained
Down 25 lbs. Labs retested: fasting glucose 92, HbA1c 5.4, fasting insulin 11, HOMA-IR 2.5, hs-CRP 1.8. Every marker moving in the right direction simultaneously. DEXA confirmed what she had feared wouldn't be true: lean muscle mass up 1.4 lbs while fat mass dropped 23 lbs. She was losing fat and gaining muscle at the same time — the outcome CrossFit had promised and never delivered.
→ Down 25 lbs; HbA1c 5.4; HOMA-IR 2.5; lean mass +1.4 lbs on DEXA
36 lbs Down — Cycles Regular — Dating Again
Down 36 lbs. Dose held at 0.5mg throughout — never escalated. Menstrual cycles now regular and consistent. Sophia re-engaged with dating for the first time in five years with genuine confidence rather than the anxiety and self-consciousness that had made it feel impossible before. She was attending in-person work events she had avoided for three years.
→ Down 36 lbs; cycles regular; dating restarted with real confidence
42 lbs Lost — Taper Begins — Exit Plan Active
Down 42 lbs at 156 lbs. GLP-1 taper initiated: 0.25mg every other week. The protocol she had been promised on day one — with a clear exit — was executing on schedule. Full-body photos posted on social media for the first time since college. The medication dependency she had feared at 28 was resolving, not deepening. Target: fully off semaglutide by month 18 with metabolic flexibility intact.
→ 42 lbs lost; taper active; off medication target month 18
"Sophia had done Whole30 twice, CrossFit for nine months, and tracked calories for six years. The reason nothing worked wasn't effort — it was that no one had run a fasting insulin or HOMA-IR on a 28-year-old and explained that at 4.9, her cells were insulin-resistant in a way that made caloric restriction almost useless for fat loss. You cannot willpower your way past a metabolic mechanism. You have to address the mechanism."
What Changed at 7 Months
Weight & Body Composition
42 lbs lost (198 → 156). 38 lbs fat lost, 3 lbs lean muscle gained per DEXA — the composition outcome CrossFit promised and never delivered. Fat loss and muscle gain simultaneously.
Prediabetes Reversed
HbA1c from 5.7 → 5.3%. Fasting glucose from 104 → 92 mg/dL. Fasting insulin from 19 → 9 mIU/L. HOMA-IR from 4.9 → 1.9. Her mother's timeline — interrupted at 28, a decade before it might have otherwise arrived.
Cycle Regulation
Irregular cycles every 35–45 days → consistent 28–30 day cycles by month 5. No exogenous hormones prescribed — the PCOS-adjacent pattern responded to insulin sensitivity correction alone.
Inflammation Resolved
hs-CRP from 4.1 → 1.4 mg/L. Ferritin normalizing. The inflammatory load that had been contributing to insulin resistance, cycle irregularity, and weight loss resistance — substantially cleared.
Sleep & Cortisol
Sleep latency from 45+ min → under 20 min by month 2. Average sleep from 6.2 → 7.5 hours. Evening cortisol pattern normalized within 6 weeks. Doom-scroll evenings replaced by meal prep and consistent bedtimes.
Built-In Exit
Dose held at 0.5mg — never escalated. Taper initiated at month 7. Full discontinuation target at month 18 with metabolic flexibility intact. The medication dependency she feared at 28 was the taper plan, not the outcome.
| Category | What Changed |
|---|---|
| Prediabetes | HbA1c 5.7 → 5.3%; HOMA-IR 4.9 → 1.9 — mother's trajectory interrupted a decade early |
| Cycles | 35–45 day irregular cycles → consistent 28–30 days without hormonal intervention |
| Food Noise | Constant background preoccupation with eating — quieted by week 2 of semaglutide |
| Evening Binge Window | Post-work hour-long eating pattern — reduced by half by month 2, eliminated by month 4 |
| Sleep | 45-min sleep latency → under 20 min; 6.2 hrs → 7.5 hrs consistently |
| Doom Scrolling | Nightly TikTok weight loss anxiety spiral → meal prep and early sleep by month 3 |
| Dating | Avoided for 5 years due to body image → re-engaged with genuine confidence at month 5 |
| Social Presence | In-person work events avoided for 3 years → attending by month 5; full-body photos posted month 7 |
| Alcohol | 6+ drinks/week → 2 drinks/week — organic reduction without mandate |
| Medication | Never escalated past 0.5mg; taper on schedule; full independence target month 18 |
"I had tried everything. I'm not someone who gives up easily — I did Whole30 twice, nine months of CrossFit, years of calorie counting. Nothing lasted. I was terrified of going on medication at 28 and being on it forever. FLOA actually explained why nothing had worked — my insulin resistance was real and measurable, and no diet app addresses that. They gave me the lowest dose possible and built the taper plan into the program from day one. Seven months later I've lost 42 pounds, my cycles are regular for the first time in years, and I'm coming off the medication on schedule. I'm not my mom's story."
Clinical Takeaways
Sophia's case answers a question that many younger patients carry silently: why does nothing work when I'm clearly trying? The answer in her case was biological, not behavioral. At HOMA-IR 4.9, her cells were insulin-resistant to a degree that made caloric restriction almost physiologically useless for sustained fat loss. The regain pattern that had followed both Whole30 attempts wasn't a failure of discipline — it was a predictable metabolic response to unsustainable restriction in an insulin-resistant environment. The CrossFit weight gain was the same story from the other direction: high-intensity exercise elevated cortisol further, compounding the insulin resistance rather than addressing it.
The PCOS-adjacent labs also mattered. Her LH:FSH ratio, suppressed SHBG, and irregular cycles were not diagnostic for PCOS — but they were mechanistically significant. The gray zone is real, and it responds to insulin sensitivity correction. By month 5, her cycles had normalized to a consistent 28–30 day pattern without any hormonal intervention. The metabolic work was the hormone work.
The medication framing decision also deserves attention. Sophia came in terrified of dependency. The protocol honored that fear rather than dismissing it. Semaglutide was chosen over tirzepatide for its gentler potency and cleaner taper pathway. The dose was never escalated. The taper plan was built in from day one. This is what a protocol designed for Metabolic Independence looks like — the medication as a tool to install the biology and habits, not a permanent crutch. The goal was always for her not to need it.
If You've Tried Everything and Nothing Has Lasted — This Is Why
Six years of dieting that didn't work isn't a character flaw. It's a diagnostic signal. If your fasting insulin and HOMA-IR have never been measured, you don't yet have the full picture. The mechanism matters more than the effort.
Individual results vary. This case study is for educational purposes only. © Dr. Jones DC — FLOA Protocol.